Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Yifei No. II (健脾益肺II号颗粒) is a traditional Chinese medicine granule formulation designed to strengthen the spleen and benefit the lungs, primarily used for treating chronic bronchitis in remission caused by spleen and lung qi deficiency. It contains herbal ingredients such as Astragalus membranaceus (huangqi), licorice (gancao), pseudostellaria root (taizishen), tangerine peel (chenpi), along with calcium gluconate, magnesium oxide, citric acid, vitamin B1, and calcium hydrogen phosphate. The formula works by invigorating the spleen and lungs, relieving cough and resolving phlegm. It is administered orally as granules dissolved in hot water.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Yifei No. II.